Hui Li

机构：Fudan University, Zhongshan Hospital of Xiamen University, Zhongshan Hospital, Sichuan Provincial Hospital of Traditional Chinese Medicine, Ministry of Education, Second Affiliated Hospital of Chengdu University of Traditional Chinese, Chengdu University of Traditional Chinese Medicine · ORCID：0000-0002-0573-4877

发表论文 12 篇 · 总被引 194 次 · h-index 6

代表论文

• CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma (2024 · Journal of Hepatology · 被引 65)
• PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy (2022 · Journal of Hepatology · 被引 54)
• ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis (2024 · Cancer Research · 被引 33)
• CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance (2025 · Advanced Science · 被引 13)
• Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma (2025 · Gut · 被引 10)
• SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma (2025 · Cell Death and Disease · 被引 7)